US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Gossamer Bio Inc (GOSS)
Gossamer Bio Inc (GOSS) ニュース

GOSS

Gossamer Bio (GOSS)

Gossamer Bio Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GOSS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/15	05 : 01	Business Wire	Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference	NASDAQ:GOSS	Gossamer Bio Inc
2024/05/11	05 : 30	Business Wire	Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:GOSS	Gossamer Bio Inc
2024/05/08	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOSS	Gossamer Bio Inc
2024/05/08	05 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GOSS	Gossamer Bio Inc
2024/05/08	05 : 01	Business Wire	Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:GOSS	Gossamer Bio Inc
2024/05/06	20 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOSS	Gossamer Bio Inc
2024/05/06	20 : 30	Business Wire	Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications	NASDAQ:GOSS	Gossamer Bio Inc
2024/05/03	21 : 02	Business Wire	Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine	NASDAQ:GOSS	Gossamer Bio Inc
2024/03/12	20 : 31	Business Wire	Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors	NASDAQ:GOSS	Gossamer Bio Inc
2024/03/05	21 : 37	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:GOSS	Gossamer Bio Inc
2024/03/05	21 : 32	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:GOSS	Gossamer Bio Inc
2024/03/05	21 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOSS	Gossamer Bio Inc
2024/03/05	21 : 31	Business Wire	Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update	NASDAQ:GOSS	Gossamer Bio Inc
2024/03/05	06 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOSS	Gossamer Bio Inc
2024/01/09	06 : 01	Business Wire	Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:GOSS	Gossamer Bio Inc
2024/01/05	07 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GOSS	Gossamer Bio Inc
2024/01/05	07 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GOSS	Gossamer Bio Inc
2024/01/05	07 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GOSS	Gossamer Bio Inc
2023/12/14	06 : 01	Business Wire	Gossamer Bio to Host Webcast to Discuss Latest Seralutinib Open-Label Extension Data on December 18, 2023	NASDAQ:GOSS	Gossamer Bio Inc
2023/12/06	07 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GOSS	Gossamer Bio Inc
2023/12/06	07 : 09	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:GOSS	Gossamer Bio Inc
2023/12/06	06 : 01	Business Wire	Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:GOSS	Gossamer Bio Inc
2023/12/05	21 : 01	Business Wire	Gossamer Bio Appoints Bob Smith as Chief Commercial Officer	NASDAQ:GOSS	Gossamer Bio Inc
2023/11/30	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOSS	Gossamer Bio Inc
2023/11/29	21 : 01	Business Wire	Gossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of Directors	NASDAQ:GOSS	Gossamer Bio Inc
2023/11/28	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOSS	Gossamer Bio Inc
2023/11/23	09 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GOSS	Gossamer Bio Inc
2023/11/23	09 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GOSS	Gossamer Bio Inc
2023/11/23	09 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GOSS	Gossamer Bio Inc
2023/11/18	06 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GOSS	Gossamer Bio Inc

Showing the most relevant articles for your search:NASDAQ:GOSS

1 2 3 4 5 6 7 8 9 10 次へ >>

BNP Paribas Issuance

Autoroutes du Sud de la ...

Highlands Bankshares (PK)

Sino Ocean (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約